 Amikacin pharmacokinetics patients high-dose cancer chemotherapy amikacin pharmacokinetics patients mean age years high-dose chemotherapy neutropenic febrile episode Patients experimental protocol high-dose anticancer chemotherapy Amikacin pharmacokinetic parameters concentrations serum single dose method Sawchuck Zaske Pharmacokinet Biopharm parameters standard methods observed amikacin volume distribution clearance elimination half-life versus liter/kg versus liters/h/kg versus Multivariate analysis albumin volume distribution elimination half-life Creatinine percentage ideal body clearance Administration dosage regimens predicted pharmacokinetic parameters subtherapeutic amikacin concentrations serum patients dosage requirements need adequate antibiotic treatment population guidelines empiric dosing patients advanced cancer intensive chemotherapy